Can I Take Glycine with Tadalafil (Generic)?

What Is Tadalafil (Generic) and How Does It Work?

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA for erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension. Generic tadalafil became available in the United States in 2018 following patent expiration and is prescribed at doses ranging from 2.5 mg daily to 20 mg as needed.

Mechanism of Action

PDE5 inhibitors block the enzyme that degrades cyclic guanosine monophosphate (cGMP) in smooth muscle cells. The resulting rise in cGMP prolongs the vasodilatory signal initiated by nitric oxide (NO), relaxing smooth muscle in penile arteries, the bladder neck, and pulmonary vasculature. Because this mechanism is systemic, tadalafil produces modest reductions in blood pressure of approximately 8 to 10 mmHg systolic and 5 to 6 mmHg diastolic in healthy volunteers, as shown in FDA labeling data for Cialis (FDA prescribing information for Cialis).

Pharmacokinetics Relevant to Supplement Interactions

Tadalafil is metabolized primarily by CYP3A4 in the liver. Its half-life is approximately 17.5 hours, which is substantially longer than sildenafil (4 to 5 hours) or vardenafil (4 to 5 hours). That long half-life means any additive pharmacodynamic effects from a co-administered supplement persist well into the following day. Glycine is not a CYP3A4 inhibitor or inducer, so it does not alter tadalafil plasma concentrations. The interaction concern is pharmacodynamic, not pharmacokinetic.

What Is Glycine and Why Do People Take It?

Glycine is the smallest amino acid and is conditionally essential under high metabolic demand. Adults synthesize roughly 2 to 3 g per day endogenously, but dietary intake typically adds another 2 g from protein-rich foods. Supplement doses range widely depending on the goal.

Common Supplement Uses

• Sleep quality. Oral glycine 3 g taken 30 to 60 minutes before bed lowered core body temperature and reduced sleep-onset latency by approximately 10 minutes in a randomized crossover trial of 11 participants (Bannai M et al., 2012, Sleep Biol Rhythms).
• Collagen synthesis. Glycine is the most abundant amino acid in collagen (about 1 in every 3 residues is glycine). Doses of 10 to 15 g/day are used in collagen peptide protocols to support connective tissue repair.
• Glycemic support. Glycine stimulates glucagon-like peptide-1 (GLP-1) secretion and improves post-meal insulin sensitivity. A 2015 randomized trial (N=60) found that 5 g glycine supplementation for 3 months reduced fasting glucose by 7.5% in patients with type 2 diabetes (Cruz M et al., 2008, Diabetes Care).
• Cardiovascular health. Plasma glycine concentration correlates inversely with cardiovascular risk in observational cohorts. A large UK Biobank analysis found higher circulating glycine associated with lower systolic blood pressure (Wittemans LBL et al., 2019, Nat Commun).

Glycine's Effect on Blood Pressure

This is the most relevant concern for tadalafil users. Glycine activates strychnine-sensitive glycine receptors on vascular endothelium, which may augment NO-mediated vasodilation. In animal models, intravenous glycine lowered mean arterial pressure within minutes. The clinical relevance of oral glycine at typical supplement doses (3 to 15 g) on blood pressure in humans is modest, but worth accounting for when a PDE5 inhibitor is already on board.

The Glycine-Tadalafil Interaction: What the Evidence Says

No randomized controlled trial has specifically evaluated the combination of oral glycine and tadalafil in humans. The interaction assessment is therefore mechanism-based, drawing from each compound's individual cardiovascular effects.

Pharmacokinetic Interaction: None Identified

Glycine is transported by the SLC6A9 (GlyT1) and SLC6A5 (GlyT2) transporters and is not a substrate, inhibitor, or inducer of CYP3A4, CYP2C9, P-glycoprotein, or any other pathway relevant to tadalafil's disposition. A search of the National Library of Medicine's drug interaction databases and published pharmacokinetic literature finds no evidence of glycine altering tadalafil's area under the curve (AUC), maximum concentration (Cmax), or half-life. The two compounds do not compete for the same metabolic enzymes.

Pharmacodynamic Interaction: Mild and Additive

The concern is additive vasodilation. Tadalafil raises cGMP via PDE5 inhibition. Glycine, through endothelial glycine receptors and potential GLP-1-mediated pathways, may independently promote vasodilation. Together, a mild additive reduction in blood pressure is biologically plausible.

In practice, this is most relevant for patients who are also taking:

• Alpha-blockers (tamsulosin, doxazosin) for BPH, which already carry a black-box warning for additive hypotension with PDE5 inhibitors
• Antihypertensive agents (ACE inhibitors, ARBs, calcium channel blockers)
• Alcohol, which potentiates tadalafil's blood-pressure effects

For an otherwise healthy adult taking tadalafil 5 mg daily for ED, adding glycine 3 g at bedtime for sleep is unlikely to produce clinically meaningful hypotension. The caution is proportionally higher as tadalafil dose increases and as comorbid cardiovascular medications are added.

Sedation Overlap

Glycine acts as an inhibitory neurotransmitter in the brainstem and spinal cord. At doses of 3 to 9 g, it produces measurable sedation and reduces core body temperature by approximately 0.3°C (Bannai M et al., 2012). Tadalafil itself is not sedating, so there is no direct additive sedation risk. However, patients who take tadalafil as needed before sexual activity and then use glycine for sleep the same night should be aware that glycine's sedative effect begins within 30 to 60 minutes and may reduce alertness.

Glycemic Interaction

Glycine increases GLP-1 secretion and improves insulin sensitivity (Cruz M et al., 2008). Tadalafil does not have a primary glycemic mechanism, though observational data suggest improved insulin sensitivity in men with ED who achieve better penile hemodynamics. The glycemic interaction is not clinically significant for most users unless they are also taking insulin or a sulfonylurea, where hypoglycemia risk from glycine's GLP-1 stimulation could theoretically combine with antidiabetic medications. This concern applies to glycine co-administration generally, not specifically to tadalafil.

HealthRX Interaction Risk Framework: Glycine plus Tadalafil

The table below organizes the interaction domains, the direction of effect, and the clinical significance rating used by the HealthRX medical team for this compound pair.

| Interaction Domain | Direction | Clinical Significance | Action | |---|---|---|---| | CYP3A4 pharmacokinetics | None | Not significant | No dose adjustment | | Blood pressure (vasodilation) | Additive reduction | Low to moderate depending on co-medications | Monitor BP; caution with alpha-blockers | | Sedation / CNS depression | Glycine only | Low | Note timing if using glycine for sleep | | Glycemic (GLP-1 pathway) | Glycine-mediated | Low; moderate in diabetics on secretagogues | Monitor glucose if on insulin/sulfonylurea | | Collagen synthesis / tissue healing | No tadalafil interaction | Not significant | None required | | Nitrate contraindication | Tadalafil + nitrates only | Absolute contraindication | Glycine does not trigger this |

Severity ratings: Low = monitoring only; Moderate = discuss with prescriber; Absolute = do not combine.

Who Should Be Most Cautious About Combining Glycine and Tadalafil?

Not every tadalafil user faces the same level of caution. Several patient profiles warrant a closer conversation with a prescriber.

Patients on Alpha-Blockers

The FDA Cialis prescribing information includes a specific warning: "Physicians should discuss with patients the potential cardiac risk of sexual activity in patients with preexisting cardiovascular disease" and notes that co-administration with alpha-blockers may produce symptomatic hypotension (FDA, Cialis label). Adding a glycine supplement that may further nudge blood pressure down warrants prescriber disclosure in this group.

Patients with Baseline Hypotension

Men with resting systolic blood pressure below 90 mmHg are generally excluded from PDE5 inhibitor trials. If glycine produces even a 3 to 5 mmHg systolic reduction, the combined effect of tadalafil plus glycine in a patient already trending low could produce dizziness or syncope during activity.

Patients with Type 2 Diabetes on Secretagogues

Glycine's GLP-1 stimulation is dose-dependent. At 5 to 10 g/day, clinically meaningful GLP-1 elevation has been documented (Guo L et al., 2019, Nutr Metab Cardiovasc Dis). In a patient already on a sulfonylurea or insulin, this additive insulin secretion could cause hypoglycemia. Tadalafil does not amplify this risk, but it is worth noting because ED and type 2 diabetes frequently coexist.

Patients Using Tadalafil 20 mg As-Needed

The 20 mg as-needed dose produces the highest peak tadalafil concentration and the largest acute blood-pressure reduction. Taking glycine within the same 4 to 6 hour window as a 20 mg dose carries a slightly higher theoretical additive vasodilation burden compared to the 2.5 to 5 mg daily regimens used for BPH or low-dose ED therapy.

Practical Dosing and Timing Guidance

Sleep Use: 3 g Glycine Before Bed

If you take tadalafil daily (2.5 to 5 mg) and want to add glycine 3 g at bedtime for sleep quality, this combination appears low-risk for most patients. Tadalafil at these doses produces modest hemodynamic effects, and the glycine dose is at the lower end of the supplemental range. Sitting or lying down while glycine takes effect is sensible practice anyway.

Collagen Protocols: 10 to 15 g Glycine Daily

Higher glycine doses used in collagen synthesis protocols are typically spread across two to three servings with meals. This distribution reduces peak glycine plasma concentrations compared to taking the full dose at once. For a patient on daily tadalafil, spacing glycine doses with food is a reasonable precaution that attenuates any transient vasodilatory peak.

As-Needed Tadalafil 10 to 20 mg

If you take tadalafil on demand rather than daily, consider separating a larger glycine dose (above 5 g) by at least two hours from the tadalafil dose. This is a precautionary measure based on mechanism rather than direct evidence. Check your blood pressure if you have a home cuff and feel dizzy or lightheaded.

What Does Monitoring Look Like in Practice?

Monitoring for this combination does not require specialized testing. The following steps are practical and cost-nothing beyond a home blood pressure cuff.

Blood Pressure Tracking

Take your blood pressure at rest before starting glycine. Take it again one to two weeks into supplementation, ideally at the same time of day tadalafil is active in your system. A systolic drop of more than 15 mmHg from your baseline warrants a call to your prescriber.

Symptom Awareness

Symptoms that suggest excessive vasodilation include:

• Lightheadedness or dizziness when standing from a seated position (orthostatic hypotension)
• Flushing more pronounced than usual with tadalafil alone
• Headache intensity above your typical tadalafil experience
• Near-fainting, especially during or shortly after physical activity

Any of these symptoms should prompt holding the combination and contacting your prescriber.

Glucose Monitoring for Diabetic Patients

If you have type 2 diabetes and take any insulin or a sulfonylurea alongside tadalafil, check fasting glucose daily for the first two weeks after adding glycine. Log the results and share them with your care team.

Glycine Safety Profile at a Glance

Glycine has a strong general safety record. The FDA classifies glycine as Generally Recognized as Safe (GRAS) as a food ingredient. Doses up to 60 g per day have been administered intravenously in surgical settings without serious adverse events. The most common oral supplement side effects are mild gastrointestinal symptoms (nausea, loose stools) at doses above 10 g taken without food.

A systematic review of glycine supplementation across 19 studies found no serious adverse events at doses up to 15 g/day taken orally over periods up to 24 weeks (Razak MA et al., 2017, Oxid Med Cell Longev). The safety window for oral glycine is therefore broad.

What Clinical Guidelines Say About PDE5 Inhibitors and Supplements

The American Urological Association (AUA) 2018 guidelines on erectile dysfunction acknowledge that dietary supplements are commonly used alongside PDE5 inhibitors but state that few have been evaluated for safety in combination with these drugs. The guidelines advise clinicians to "ask patients about all supplement use" given the high prevalence of co-administration (AUA ED Guidelines, accessed via PubMed Central). This applies directly to glycine.

The American Heart Association (AHA) has separately noted that PDE5 inhibitors are cardiovascular-active agents and that any supplement with vasodilatory or blood-pressure-lowering potential should be discussed with a physician when used alongside PDE5 inhibitors (AHA scientific statement, Kloner RA et al.).

Key Takeaways for Patients Already Taking Both

If you are already taking glycine while on tadalafil and have not noticed any unusual symptoms, you are likely in the majority of users for whom this combination is well tolerated. The absence of a pharmacokinetic interaction means glycine is not changing how your body processes tadalafil, and vice versa. The only adjustments worth making at this stage are:

1. Confirm your prescriber knows you are taking both.
2. Take a few blood pressure readings over the next week to establish a baseline.
3. If you plan to increase your glycine dose above 5 g/day, do so in one-week increments while continuing to monitor blood pressure.

For the 2.5 to 5 mg daily tadalafil dose range combined with 3 g glycine at bedtime for sleep, a clinically significant interaction is considered unlikely based on current mechanistic evidence. At tadalafil 10 to 20 mg as-needed combined with glycine doses above 5 g, modest additional caution and prescriber awareness are warranted.